
Attorneys representing employers and health plan enrollees in a long-running antitrust suit against Sacramento, Calif.-based Sutter Health filed a notice of appeal April 26.
The $411 million class-action case, Sidibe v. Sutter Health, centered on Sutter Health’s “all-or-nothing” contracts with five major health insurers — Anthem Blue Cross, Blue Shield, Aetna, Health Net and UnitedHealthcare. Plaintiffs alleged that Sutter Health used its market power to negotiate restrictive contracts with the major insurers and overcharge millions of premium-paying patients. The lawsuit had a certified class of around 3 million members who purchased health policies from the insurers since 2011.
A jury sided with Sutter Health in March after eight hours of deliberations over a two-day span.
Attorneys representing plaintiffs in the case are seeking to revive the case by appealing to the 9th Circuit Court of Appeals.
Matthew Cantor, a lead attorney representing the plaintiffs, told the Sacramento Business Journal that attorneys believe the trial outcome would have been different if the judge gave the jury accurate instructions and if his team were able to present key evidence to the jury.
“The erroneous instructions were vague and didn’t give the jury the kind of guidance that it needed in this case to make correct factual determinations,” Mr. Cantor told the Business Journal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas